Skip to main content
Clinical Trials/JPRN-UMIN000009563
JPRN-UMIN000009563
Completed
Phase 2

Randomized study comparing simultaneous injection with sequential injection of Fulvestrant - Randomized study of injection methods of Fulvestrant

Yokohama City University Medical Center0 sites40 target enrollmentDecember 17, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Postmenopausal breast cancer
Sponsor
Yokohama City University Medical Center
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2012
End Date
December 31, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who are impossible to be enrolled with psychological diseases or disorder 2\)Inappropriate patients by investigator' decision

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomized comparison of two injection techniques for ultrasound-guided supraclavicular block following arthroscopic shoulder surgery; subfascial vs extrafascial injectioDiseases of the musculo-skeletal system and connective tissue
KCT0003794Inha University Hospital50
Active, not recruiting
Not Applicable
Randomized trial comparing injection frequency between Aflibercept and Ranibizumab in patients with Central Retinal Vein Occlusion with a treat and extent algorithmCentral retinal vein occlusionTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2014-001047-21-SESankt Eriks Eye Hospital
Recruiting
Phase 3
Investigating the effect of simultaneous infusion of lidocaine and ketamine compared to single infusion of lidocaine and ketamine on neuromonitoring in spine surgeries
IRCT20230204057318N2Shahid Beheshti University of Medical Sciences90
Not yet recruiting
Phase 4
Comparative Randomized ,Single Dose, Two-Way Crossover, Open-label Study to Determine Bioequivlence of Olanzapine 5 mg Orally Disintegrating Tablets Formulations, Zyprexa Zydis (5 mg) and ZOLAN GPO (5 mg), after Oral Administration to Healthy Thai Volunteers under Fasting ConditionsHealthy volunteers
TCTR20171204002Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University30
Completed
Phase 3
A clinical trial comparing low dose versus standard dose of intravenous paracetamol for PDA closure in very premature babiesHealth Condition 1: null- Premature neonates at birth
CTRI/2017/10/010012Surya Childrens Medicare Private limited102